Responses to Treatment can Differentiate Chronic Active Liver Disease with Cholangitic Features from the Primary Biliary Cirrhosis Syndrome
- 1 September 1976
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 71 (3) , 444-449
- https://doi.org/10.1016/s0016-5085(76)80453-2
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared.Gut, 1975
- Hepatobiliary diseases associated with serum antimitochondrial antibody (AMA)The American Journal of Medicine, 1973
- CONTROLLED TRIAL OF PREDNISONE AND AZATHIOPRINE IN ACTIVE CHRONIC HEPATITISThe Lancet, 1973
- Cholestasis in active chronic hepatitisDigestive Diseases and Sciences, 1972
- Chronic active hepatitis with unusual histologic features: Report of a caseThe Journal of Pediatrics, 1971
- CHRONIC ACTIVE HEPATITIS WITH FEATURES OF PRIMARY BILIARY CIRRHOSISThe Lancet, 1971
- The immunology of liver diseaseThe American Journal of Medicine, 1970
- Immunological and histological studies in primary biliary cirrhosisJournal of Clinical Pathology, 1970
- TREATMENT OF PRIMARY BILIARY CIRRHOSIS WITH AZOTHIOPRINEThe Lancet, 1967
- Post-necrotic cirrhosis with chronic cholestasisGut, 1963